The Economic Impact of AIDS in the United States.

Bloom, David E.; Carliner, Geoffrey

Notes FAQ Contact Us

Back to results

Peer reviewed

ERIC Number: EJ366662

Record Type: CIJE

Publication Date: 1988

Pages: N/A

Abstractor: N/A

ISBN: N/A

ISSN: N/A

EISSN: N/A

Available Date: N/A

The Economic Impact of AIDS in the United States.

Bloom, David E.; Carliner, Geoffrey

Science, v239 n4840 p604-10 Feb 5 1988

Claims that the lifetime cost of medicare per acquired immune deficiency syndrome (AIDS) patient will not exceed $80,000, an amount similar to the cost of treating other serious illnesses. Argues that the total projected costs for treating AIDS patients between 1981 and 1991 will not exceed $22 billion. (TW)

Descriptors: Acquired Immune Deficiency Syndrome, Cost Estimates, Costs, Disease Control, Health Education, Medical Services, Science and Society, Science Education, Scientific and Technical Information, Sexually Transmitted Diseases

Publication Type: Journal Articles; Reports - Descriptive; Opinion Papers

Education Level: N/A

Audience: Practitioners; Researchers; Policymakers

Language: English

Sponsor: N/A

Authoring Institution: N/A

Grant or Contract Numbers: N/A

Author Affiliations: N/A